The attenuated Sabin strain of poliovirus type 1 (PV-1) differs from the neurovirulent PV-1 Mahoney strain by 55 nucleotide mutations. Only one of these mutations (A-480---G), in the 5' noncoding (5' NC) region of the genome, is well characterized, and it confers a strong attenuating effect. We attempted to identify genetic attenuation determinants in the 3'-terminal part of the Sabin 1 genome including the 3D polymerase (3DPol) gene and the 3' NC region. Previous studies suggested that some of the 11 mutations in this region of the Sabin 1 genome, and in particular a mutation in the polymerase gene (U-6203--C, Tyr-73-*His), are involved to some extent in the attenuation of PV-1. We analyzed the attenuating effect in the mouse model by using the mouse-adapted PV-1/PV-2 chimeric strain v510 (a Mahoney strain carrying nine amino acids of the VP1 capsid protein from the Lansing strain of PV-2). Mutagenesis of locus 6203 was performed on the original v510 (U-6203--C) and also on a hybrid v510/Sabin 1 (C-6203--U) carrying the downstream 1,840 nucleotides of the Sabin 1 genome including the 3D"" and 3' NC regions. Statistical analysis of disease incidence and time to disease onset in numerous mice inoculated with these strains strongly suggested that nucleotide C-6203 is involved in the attenuation of the Sabin 1 strain. Results also suggested that, among the mutations located in the 3DW'" and 3' NC regions, nucleotide C-6203 may be the principal or the only one to be involved in attenuation in this mouse model. We also found that the effect of C-6203 was weaker than that of nucleotide G-480; the two nucleotides acted independently and may have a cumulative effect on attenuation. The U-6203,-C substitution also appeared to contribute to the thermosensitivity of the Sabin 1 strain. Poliovirus (PV), an enterovirus of the Picornaviridae family, is the causative agent of poliomyelitis. It replicates in the human digestive tract and may induce paralysis by infecting and destroying motor neurons (7, 15) . Attenuated strains of all three serotypes have been selected by numerous passages of wild-type strains in monkey tissues in vivo and in vitro (49). These strains (Sabin 1, 2, and 3), which replicate in the human gut and induce strong immunity, have been efficiently used as oral vaccines. Studies of the genetic basis of attenuation of PV vaccine strains have been greatly facilitated now that the sequences of attenuated and virulent strain genomes are known (reviewed in references 38 and 44).
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The PV genome is a polyadenylated single-stranded RNA of positive polarity (7, 441 bases long for PV type 1 [PV-1]) (for a review, see reference 51). Two noncoding regions flank the single large open reading frame which codes for the viral structural (VP1 to VP4) and nonstructural polypeptides including the RNA-dependent RNA polymerase (3D1"'). The 5' noncoding (5' NC) region, terminally linked to a small viral protein, VPg, is involved in viral replication and in cap-independent initiation of translation (3, 42) . The short 3' NC region is thought to be involved in viral replication (50) .
The genome of the Sabin 3 strain differs from that of the neurovirulent wild-type progenitor by 12 mutations, and it has been found that among these mutations only three determine the attenuation phenotype (55, 58) . In contrast, the genome of the Sabin 1 strain differs from that of its parental virulent Mahoney virus (PV-1 Mahoney) by 55 point mutations (39) . The characterization of recombinant viruses * Corresponding author.
(between attenuated and virulent strains of PV-1) has shown that determinants of attenuation are spread over the entire viral genome (1, 40) . A point mutation in the 5' NC region of the Sabin 1 genome, at position 480 (A-*G), is the only well-characterized mutation known to be involved in the attenuation of PV-1 (21, 32) . A similar strong attenuating mutation is found in the 5' NC region of the Sabin 2 and Sabin 3 strain genomes at nucleotide positions 481 and 472, respectively (27, 31, 47, 58) . In the Sabin 3 strain, this mutation has been shown to affect viral replication in human neuroblastoma cell lines (28) and the level of translation of the genome in an acellular system (54) , probably as the result of the alteration of the secondary structure of the 5' NC region (43, 52) . Previous studies of PV-1 attenuation suggested that the 3'-terminal part of the Sabin 1 genome including the 3DPo1 gene and the 3' NC region is also involved to some extent in the attenuation of PV-1 in monkeys (40) . In particular, a mutation at position 6203 (U-C) leading to an amino acid change at position 73 of the 3D polymerase (Tyr-73--+His) has been highlighted as a possible determinant of the thermosensitivity and/or attenuation of PV-1 (12, 57) .
All three PV serotypes induce paralysis only in primates; thus genetic attenuation determinants of PV strains have been studied mainly in monkeys. However, some PV strains, in particular the Lansing strain of PV-2 (PV-2 Lansing), have been adapted to mice and can induce poliomyelitis in animals following intracerebral inoculation (44) . Moreover, it has been shown that PV-1 Mahoney acquires the ability to cause paralysis in mice if the exposed B-C loop (amino acids 94 to 102) of its capsid protein VP1 is replaced by that of PV-2 Lansing (33, 35) . Recent studies with mice confirming the attenuating role of the G-480 Sabin 1 nucle-AN ATTENUATION DETERMINANT OF POLIOVIRUS TYPE 1   4631 otide have suggested that genomic determinants important for PV-1 attenuation could be analyzed with a mouseadapted PV1/PV2 strain (32) .
In this work, we used this mouse model to study the role played by the mutation at position 6203 of the Sabin 1 genome in the attenuation of PV-1 (the U-6203--C substitution in the Sabin 1 genome compared with the PV-1 Mahoney genome will be referred to as the C-6203 mutation). We also studied the relationship of the C-6203 mutation to the other Sabin mutations in the 3DI)r gene and in the 3' NC region as well as its relationship to the known attenuating mutation in the 5' NC region of the Sabin genome (the G-480 mutation). This was done by constructing mutant and recombinant strains by using the cDNAs of the Sabin 1 strain and of the mouse adapted PV-1/PV-2 strain. Characterization of the viral strains showed that the C-6203 mutation in the 3D polymerase gene is one of the mutations implicated in the thermosensitivity of the Sabin 1 strain. Results strongly suggested that the C-6203 mutation is involved in the attenuation of the Sabin 1 strain. Of the mutations located in the 3DPOl and 3' NC regions, the C-6203 mutation may be the main or the only one to be involved in attenuation in this mouse model. It 40, which has previously been shown to have no effect on the infectivity of cDNA for primate cells (22) .
Plasmid pSabin 1/PV2. To construct the Sabin 1/PV-2 hybrid, in which the VP1 B-C loop of the Sabin 1 strain (amino acids 94 to 102) was replaced by that of PV-2 Lansing, we used the plasmid pJF C82 (17) . Plasmid pJF C82 is identical to pVS(1)IC-O(T) except that a mutagenesis cartridge was generated by introducing the unique restriction sites SalI and SacI at positions 2753 and 2790 of the viral cDNA, respectively. Annealed synthetic oligonucleotides 5'-TCGATAATGATGCTCCAACAAAGCGTGCCAGTAA GCT and 5'-TACTGGCACGClITGTTGGAGCATCATTA, corresponding to PV-2 Lansing sequences, were ligated to the SalI-SacI-digested pJF C82 to yield plasmid pSabin 1/PV2.
Transfection and virus stocks. Plasmids containing fulllength PV infectious cDNAs and regulatory sequences of simian virus 40 were transfected into simian Vero cells (2.5 ,ug of DNA per 106 cells) by the calcium phosphate technique as previously described (13) . Transfected cells were incubated at 34°C until the cytopathic effect was complete (between 3 and 6 days). Virus was harvested and amplified by one or two passages after transfection, on HEp-2c cells infected at a multiplicity of infection of approximately 1 PFU per cell. After 18 h at 34°C, remaining cells and supernatants were submitted to three cycles of freezing-thawing and clarified; the resulting virus stocks were maintained at -30°C. When necessary, viruses were concentrated by centrifugation for 2 h at 30,000 rpm in a Kontron 50.38 rotor at 4°C and resuspended in cell culture medium (Dulbecco's modified minimum essential medium supplemented with 2% newborn calf serum and 50 p,g of gentamicin per ml).
Viruses v510, vKSM, etc., were thus recovered from transfection with plasmids pAM510, pKSM, etc., respectively. Viruses v5lOA and vSl were recovered from pAM51OAb and pVS (1) ment length polymorphism assay. Viral RNA was extracted as previously described (32) . Briefly, HEp-2c cells were infected with the appropriate virus stock and were lysed (5 h after infection) in the presence of 0.5% Nonidet P-40. Cytoplasmic RNAs were recovered by phenol-chloroform extraction in the presence of 1% sodium dodecyl sulfate and sequenced by using avian myeloblastosis virus reverse transcriptase (18) . The presence of the Sabin-like nucleotide at position 7441 of the 3' NC region of the PV genome was confirmed by sequencing as previously described (10) but using a cDNA primer poly (dT)23 poly (dC); fragments synthesized from PV-1 Mahoney RNA are 1 base shorter than those derived from Sabin 1 RNA, a difference which can be detected on a sequencing gel. This is due to the presence of GAG(A)n and GAGG(A)n at the ends of the PV-1 Mahoney and Sabin 1 genomes, respectively.
In some cases, the nature of nucleotide 6203 was verified by restriction fragment length polymorphism analysis using the RsaI restriction enzyme (41) .
Thermosensitivity. (Fig. 1) . Then, to analyze the possible relationship between the C-6203 and other mutations carried by the 3DPo1 gene and the 3' NC region of the Sabin 1 genome, we constructed a hybrid vS10-Sabin 1 strain (vH) which carried the 3'-terminal 1,840 bases of the Sabin 1 genome. In this region, the genome of the attenuated Sabin 1 strain differs from that of the neurovirulent Mahoney virus by 11 point mutations including C-6203. Three mutations of the nine located in the 3DP" gene induce amino acid changes at codons 53, 73, and 362 (nucleotide positions 6143, 6203, and 7071, respectively). Two other mutations are located in the 3' NC region of the genome (nucleotide positions 7410 and 7441). To discriminate the specific effect of the C-6203 mutation from the possible effects of the other 10 mutations, the C-6203 nucleotide in the vH hybrid strain genome was replaced by the Mahoney T-6203 nucleotide to produce strain vHM (Fig. 1) .
Furthermore, we looked for possible joint effects of the strong attenuating mutation G-480 of the 5' NC region and the mutations carried by the 3'-terminal part of the Sabin 1 genome. Strains similar to those described above were constructed by using a plasmid which carries the cDNA corresponding to the original mouse-adapted strain vS10 with the additional mutation G-480 (strain vSlOA) (32) . These constructions resulted in strains vAS, vHA, and vHAM, all carrying the G-480 nucleotide in the 5' NC region but having different 3' genomic ends (Fig. 1) Thermosensitivities of viruses. To test the effects of introduced mutations on the thermosensitivities of the strains, the reproductive capacity of each recombinant strain at 34WC and 39.5 or 40°C (Rct marker) was determined (see Materials and Methods for details) (Fig. 2) . The Sabin 1 strain (vS1) was thermosensitive and exhibited a loss of more than 5 log1o 50% tissue culture infective dose units per ml between 34 and 40°C, whereas the original vS10 strain was not thermosensitive as previously reported (24, 33) .
The introduction of the Sabin-like nucleotide at position 480 of the 5' NC region (vSlOA) had a very slight effect on thermosensitivity, with a loss of around 1 log1o 50% tissue culture infective dose unit per ml between 34 and 40°C. These results confirmed that the G-480 nucleotide is a very weak determinant of thermosensitivity (21, 32 the Sabin 1 genome were shown to be partially thermosensitive compared with the original v510, v5lOA, and Sabin 1 strains. This partial thermosensitivity was abrogated when the Sabin mutation at position 6203 of the hybrid genome was replaced with the wild-type nucleotide (vHM and vHAM). Thus, the mutation C-6203 (at codon 73 of the Sabin 1 polymerase) is involved in the thermosensitivity of the vaccinal strain. However, the introduction of the C-6203 mutation alone in the 3DP"' gene of v510 and v5lOA (wildtype context) (vKSM and vAS) did not result in thermosensitivity. This suggests that the C-6203 mutation is phenotypically linked with other mutations carried by the 3' part of the Sabin 1 genome extending from the 3DP"" gene to the 3' NC region.
Neurovirulence of viruses in mice. To test the neurovirulence of virus strains, mice were intracerebrally inoculated with various dilutions of viral stocks. This experiment was repeated for each virus by making use of two different viral stocks obtained by independent cell transfection experiments. The PD50 was determined for each strain (Fig. 3) . The PD50 of strains (v51OA, vAS, vHAM, and vHA) carrying a Sabin-like nucleotide at position 480 were roughly 2 loglo PFU higher than that of the parental v510 strain. This confirmed the strong attenuating effect of this mutation as previously shown with mice by using v5lOA (32) and with monkeys by using PV-1 Mahoney/Sabin 1 recombinant strains (21 (Fig. 4) . Viruses (Fig. 4) to the Kaplan-Meier method, and differences between virus-associated disease development were tested pairwise for significance by the log-rank test. *, statistically significant (P < 0.05).
mice, and full reversion to the wild type was never observed. Therefore, it seems unlikely that base A-7441 plays a role in the neurovirulence of the recombinant strains studied.
To determine the level of attenuation of strains carrying the two identified attenuating mutations (G-480 and C-6203), we tried to compare their neurovirulence with that of the Sabin 1 strain. To circumvent host restriction genetic determinants which could block infection of mice with the Sabin 1 strain, we constructed a new hybrid Sabin 1/PV-2 strain by substituting VP1 amino acids 94 to 102 of the Sabin 1 strain with those of PV-2 Lansing (the same type 2 residues which confer a mouse-adapted phenotype to the wild-type strain of PV-1). No paralyses in mice inoculated with the highest dose of this hybrid strain (PD5O > 8.3 log10 PFU) or in those inoculated with the parental Sabin 1 strain were observed. Thus the Sabin 1/PV-2 strain might be more attenuated in mice than strains (vAS and vH) carrying both the C-6203 and the G-480 Sabin mutations. However, more experiments are needed to ascertain that type 2 residues inserted in the Sabin 1 capsid allow the Sabin 1 strain to bypass mouse-specific host restriction.
DISCUSSION
To determine the role played by the 3' part of the Sabin 1 genome (the 3D polymerase gene and 3' NC region) in attenuation, we circumvented the need for monkeys by using a strain of PV-1 rendered neurovirulent for mice by substituting nine amino acids of its capsid protein VP1 with those of the mouse-adapted PV-2 Lansing (32, 33) . We focused our attention on the Sabin 3DPII C-6203 mutation, which has previously been implicated as a possible determinant of the thermosensitivity and/or attenuation of PV-1 (12, 57) . We also studied the relationship between the C-6203 mutation and the strongly attenuating G-480 determinant in the 5' NC region of the Sabin 1 genome. Comparisons of the neurovirulence of recombinant and mutagenized strains in numerous mice allowed us to perform survival data analysis and thus to show that the C-6203 mutation is involved in attenuation. C-6203 may be the only, or at least the main, mutation of the 11 mutations carried by the 3DPI gene and the 3' NC region to be involved in attenuation in this mouse model.
The attenuating effect in mice of the C-6203 mutation appeared to be weaker than that of the G-480 mutation. The difference between the PD50 of viruses carrying the C-6203 mutation and that of the original PV-1/PV-2 strain was about 0.7 log1o PFU (compared with a difference of 2 log1o PFU for viruses with the G-480 mutation). Although small, this difference in neurovirulence was statistically significant as determined by comparing disease incidences plus times to disease onset (Kaplan-Meier method). A similar methodology has already been used to compare susceptibility and resistance to PV-induced paralysis of inbred mouse strains (20) . Only relatively strong attenuating mutations have previously been analyzed by comparing PD50 values for mice (32, 34, 47) . Our results show that survival data analysis could be helpful for analyzing weak determinants of PV attenuation. This statistical method could be adapted to compare the neurovirulence of PV mutant strains, or vaccine lots, in transgenic mice carrying the human PV receptor (these animals are susceptible to all PV serotypes) (25, 46) .
The results previously obtained with mice in analyses of attenuation determinants carried by the 5' NC regions of all three serotypes (27, 32, 47) correlate well with those for monkeys (21, 31, 58) . A recombinant PV-1 Mahoney carrying the 3'-terminal part of the Sabin 1 strain (the 3DP°and 3' NC regions) was shown to be weakly attenuated in monkeys (40) . Our results with a similar construction (strain vH) but a different animal model confirmed that the 3' part of the Sabin 1 genome, and in particular the C-6203 mutation, is involved in the attenuation of PV-1 in mice. Despite the fact that with this kind of approach we cannot rule out that suppressive mutations could occur elsewhere in the genome of the recombinant strains used, several precautions were taken to minimize the roles of such events (see Results). Our data thus suggested that the other 10 mutations carried by the 3DP1 and 3' NC regions of the Sabin 1 genome did not seem to play significant roles in attenuation. These mutations include, in particular, the G-7441 mutation (at the end of the 3' NC region), which has been shown to revert to the wild type in recombinant type 3-type 1 strains isolated from vaccinees (10) and, in conjunction with other mutations, in neurovirulent Sabin 1 mutants (12) . Partial reversion of G-7441 was also found for viruses derived from some of our paralyzed mice, but this did not seem to be significantly linked with neurovirulence. The attenuated strain of PV-3 also carries a mutation just upstream from the poly(A) tract (A-)G at position 7432). This mutation was found not to be significantly involved in attenuation of PV-3 in monkeys (58) .
Although the estimation of PD50 values suggested that the (14) . Previous work has suggested that the reversion at the 3DP°' locus in vaccinees could be linked to temperature selection pressure (12) . This mutation appeared to be a critical factor in the moderate thermosensitivity expressed by the 3'-terminal part of the Sabin 1 genome (the 3Dr-" gene and 3' NC region); reversion at this locus to the wild type suppressed this thermosensitivity. However, the introduction of this reversion alone into the original Sabin 1 strain did not induce any apparent change in its thermosensitivity (not shown). Thus, the C-6203 mutation is only one of numerous mutations involved in the thermosensitivity of the Sabin 1 strain. This is in agreement with the results of previous studies showing that determinants of the Sabin 1 virus thermosensitivity map in the 3'-terminal part of the genome and also in each of two genomic fragments including the 5' NC region and the capsid protein-encoding region (38, 40) .
Moreover, the C-6203 mutation introduced alone into the wild-type background strain v510 did not cause a thermosensitive phenotype. This suggests that thermosensitivity results from interaction with at least one other of the 10 mutations carried by the 3DIP°and the 3' NC region of the PV genome. We are currently mapping the loci which are phenotypically linked to the C-6203 mutation. Amino acid changes at positions 53 and 362 of the polymerase and the G-7441 mutation appeared to be good candidates for this investigation. However, there are numerous other silent mutations in the 3DPOI gene and 3' NC region which may be involved in RNA secondary structure and/or in RNA replication. Thermosensitive RNA synthesis mutants have been isolated from PV cDNAs whose 3' NC regions had been mutagenized (50) . Although it is unlikely, we also cannot exclude that mutations leading to amino acid changes (including the C-6203 mutation) may act on RNA secondary structure rather than on the 3Dr enzyme activity.
The thermosensitive phenotype linked to the C-6203 mutation did not strictly correlate with attenuation in mice; vKSM carries this single mutation and is partially attenuated but not thermosensitive. A similar result has already been described for the G-480 Sabin mutation (21, 32) . It is unclear which of the viral functions are affected by the C-6203 mutation and what their roles in attenuation and/or in thermosensitivity may be. Poliovirus RNA polymerase mutants which have an RNA synthesis defect have been described, and some of them were thermosensitive (2, 6, 9, 11, 23) . None of the identified mutations map close to position 6203. The C-6203 mutation also does not appear to be close to mutations affecting the in vitro polymerase activity (8, 48) or close to the critical YGDD motif common to many viral polymerases (19) . In vitro studies nevertheless suggested that at least one of two Sabin mutations affecting the 3DP°1 gene at nucleotide positions 6143 (G--A, Asp-53--*Asn) and 6203 may influence the initiation of viral RNA synthesis above 38°C through a thermosensitive block of urydilylation of the viral protein VPg (57) . These observations and our results suggest that the 3DPIo C-6203 mutation might affect viral RNA replication and therefore PV multiplication in murine neurons.
In conclusion, we have looked for PV-1 attenuation determinants using a mouse model. By evaluating neurovirulence in numerous mice with tests that take into account disease incidence and time to disease onset, we were able to show that a mutation in the RNA polymerase of PV-1 (the C-6203 mutation) contributes weakly but significantly to the attenuation of the Sabin 1 strain in this animal model.
